Tumour budding: a promising parameter in colorectal cancer

Por Lugli, A, Karamitopoulou, E, Zlobec, I
Publicado em 2012

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer

Por Koelzer, V H, Karamitopoulou, E, Dawson, H, Kondi-Pafiti, A, Zlobec, I, Lugli, A
Publicado em 2013

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic c...

Por Galván, J A, Zlobec, I, Wartenberg, M, Lugli, A, Gloor, B, Perren, A, Karamitopoulou, E
Publicado no Br J Cancer (2015)

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer

Por Lugli, A, Karamitopoulou, E, Panayiotides, I, Karakitsos, P, Rallis, G, Peros, G, Iezzi, G, Spagnoli, G, Bihl, M, Terracciano, L, Zlobec, I
Publicado em 2009